Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000146·Akero Therapeutics, Inc.
Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
Ordinary Shares · CUSIP: 00973Y108
Event date: 2025-03-31
- Filing-level shares
- 7,068,994
- Percent of class
- 8.9%
- JANUS HENDERSON GROUP PLC
Shares: 7,068,994 · Class: 8.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000146
- Form type
- SCHEDULE 13G/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership